Mosaic ImmunoEngineering (CPMV) Shares Outstanding (2010 - 2026)
Mosaic ImmunoEngineering (CPMV) posted quarterly Shares Outstanding (Entity) of $7.2 million for Q1 2026, little changed year-over-year from $7.2 million in Q1 2025, and little changed quarter-over-quarter from $7.2 million in Q4 2025.
Mosaic ImmunoEngineering (CPMV) Shares Outstanding (2010 - 2026) Analysis & Trends
Mosaic ImmunoEngineering's Shares Outstanding (Entity) history runs 17 years deep, the most recent figure standing at $7.2 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) changed 0.0% year-over-year to $7.2 million; the TTM figure through Mar 2026 stood at $7.2 million (changed 0.0% YoY), while the FY2025 annual figure was $7.2 million, changed 0.0% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $7.2 million, roughly flat from $7.2 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $7.2 million in Q4 2022, with the low at $7.2 million in Q2 2023.
- The 5-year median for Shares Outstanding (Entity) is $7.2 million (2022), against an average of $7.2 million.
- The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) soared 38.6% in 2022, then decreased 0.06% in 2023.
- Mosaic ImmunoEngineering's Shares Outstanding (Entity) stood at $7.2 million in 2022, then changed by 0.0% to $7.2 million in 2023, then changed by 0.0% to $7.2 million in 2024, then changed by 0.0% to $7.2 million in 2025, then changed by 0.0% to $7.2 million in 2026.
- Business Quant data shows CPMV's Shares Outstanding (Entity) at $7.2 million in Q1 2026, $7.2 million in Q4 2025, and $7.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | Mosaic ImmunoEngineering | 3.68 Mn | 3.68 Mn | - | 7.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.24 Mn |
| Dec 31, 2025 | 7.24 Mn |
| Sep 30, 2025 | 7.24 Mn |
| Jun 30, 2025 | 7.24 Mn |
| Mar 31, 2025 | 7.24 Mn |
| Dec 31, 2024 | 7.24 Mn |
| Sep 30, 2024 | 7.24 Mn |
| Jun 30, 2024 | 7.24 Mn |
| Mar 31, 2024 | 7.24 Mn |
| Dec 31, 2023 | 7.24 Mn |
| Sep 30, 2023 | 7.24 Mn |
| Jun 30, 2023 | 7.24 Mn |
| Mar 31, 2023 | 7.24 Mn |
| Dec 31, 2022 | 7.24 Mn |
| Sep 30, 2022 | 7.24 Mn |
| Jun 30, 2022 | 7.24 Mn |
| Mar 31, 2022 | 7.24 Mn |
| Dec 31, 2021 | 6.71 Mn |
| Sep 30, 2021 | 7.22 Mn |
| Jun 30, 2021 | 7.22 Mn |